Navigation Links
Neurotechnology Industry Reports Record Global Growth of $130.5 Billion in 2007
Date:5/8/2008

NeuroInsights unveils expanded fourth edition of comprehensive market analysis and strategic investment report at Neurotech Industry Conference

SAN FRANCISCO and BOSTON, May 8 /PRNewswire/ -- NeuroInsights, the neurotech market authority, announced today the release of the organization's fourth annual comprehensive investment guide and market analysis of the global neurological disease and psychiatric illness markets. Unveiled during the annual Neurotech Industry Investing and Partnering Conference in Boston, this 400-page report enables investors, companies and governments to assess opportunities, calculate risks and understand the dynamics of this continually changing market.

The Neurotechnology Industry 2008 Report: Drugs, Devices and Diagnostics for the Brain and Nervous System tracks market movements that help guide strategic business development and investment decisions in neurotech. This year's report provides an in-depth look at more than 16 brain and nervous system disorders and treatments in development at over 500 public and private companies, including: Alzheimer's disease, addiction, ADHD, anxiety, depression, epilepsy, migraine, mild cognitive impairment, multiple sclerosis, obesity, pain, Parkinson's disease, schizophrenia, age-related macular degeneration, sensory disorders, sleep disorders, stroke and traumatic brain injury. Corporate financing, market activity, growth drivers and global industry conditions that make up the obstacles and opportunities facing the industry are fully assessed with detailed insights.

Specific findings from the Neurotechnology Industry 2008 Report show that in 2007:

-- Brain-related illnesses represent the largest unmet medical market with

two billion people worldwide

-- Venture capital investment in neurotechnology reached an all-time high

at $1.77 billion

-- More than 250 investors participated in neurotech financings

-- Global neurotech industry revenues rose 8.3% to $130.5 billion

-- Neuropharmaceuticals recorded revenues of $109 billion and 8% annual

growth

-- Neurodevices recorded revenues of $5.5 billion and 22% annual growth

-- Neurodiagnostics recorded revenues of $16 billion and 6% annual growth

"The neurotechnology industry made substantial gains in 2007, which has continued into 2008," said Casey Lynch, Managing Director of NeuroInsights. "Commercial neuroscience represents one of the fastest-growing and critically needed sectors of the healthcare industry. In 2007, this was underscored in the launch of several important industry initiatives, including the creation of the NASDAQ NeuroInsights Neurotech Index in September."

Specific milestones from the report were presented during NeuroInsights' annual Neurotech Industry Investing and Partnering Conference, hosted in partnership with the Neurotechnology Industry Organization. This conference, being held at the Westin Copley Place in Boston today and tomorrow, is the premier global forum where investors, executives, entrepreneurs, scientists and others involved in the development of new treatments and diagnostics for the brain and nervous system come together to shape the future of their organization and the industry.

The Neurotechnology Industry 2008 Report: Drugs, Devices and Diagnostics for the Brain and Nervous System is now available for purchase in book or digital format at http://www.neuroinsights.com/marketreports/marketreport2008.html

About NeuroInsights

NeuroInsights is the world's leading neurotechnology research and advisory firm. As the neurotechnology market authority, NeuroInsights helps investors, industry and society understand and profit from the rapid growth in drugs, devices and diagnostics for the brain and nervous system. NeuroInsights provides market reports, investment information, industry events and strategic advisory services to venture funds, startups, corporations, governments and financial institutions. For more information, visit http://www.neuroinsights.com.

Contact:

Casey Lynch

NeuroInsights

(415) 229-3225

casey@neuroinsights.com


'/>"/>
SOURCE NeuroInsights
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Neurotechnology Industry Organization Unveils Top 10 Neuroscience Trends of 2007
2. Alseres Pharmaceuticals, Inc. to Present at The Neurotech Industry Investing & Partnering Conference
3. Facet Solutions, Inc. Appoints Industry Veteran to Board of Directors
4. Anthem Blue Cross and Blue Shield in Connecticut Introduces Industrys First Electronic Tool to Help Members Search In-Network Doctors and Hospitals; Transparency Tool to Enable Searches Via Web-Enabled Cell Phones or Hand-Held Devices
5. Anthem Blue Cross and Blue Shield Introduces Industrys Most Comprehensive Transparency Initiative to Wisconsin
6. Pharma Industry Group Favors Obama as Next President
7. Key Industry and Government Officials to Address Medical Technology Executives
8. China Medicine Corporation Selected to Represent Biotechnology Industry of Guangzhou City at 2008 Annual BIO International Convention
9. The National Association of Specialty Health Organizations to Recognize Excellence in Technology Education With Industry Award
10. Siemens Healthcare Executives Recognized With New Industry Leadership Positions
11. Entertainment Industry Foundation Revlon Run/Walk for Women Celebrates 11 Years in New York City on Saturday, May 3
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... KS (PRWEB) , ... June 27, 2016 , ... TopConsumerReviews.com ... retailers of Eyeglasses . , Millions of individuals in the United States and ... have become a way to both correct vision and make a fashion statement. Even ...
(Date:6/26/2016)... , ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal ... personalized through a fitness app. The fitness app plans to fix the two major problems ... offer a one size fits all type program , They don’t eliminate all ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, ... Board will take whatever measures required to build a ... stock which is currently listed on the OTC Markets-pink ... Company Chairman and CEO, "We are seeing an anomaly ... to understand, not only by the Company, but shareholders ...
(Date:6/24/2016)... 24, 2016  Collagen Matrix, Inc., ("Collagen Matrix") ... manufacturing of collagen and mineral based medical devices ... Bill Messer has joined the company ... leverage the growing portfolio of oral surgery, neurosurgery, ... Bill joins the Collagen Matrix executive team as ...
(Date:6/24/2016)... 24, 2016 ... the addition of the " Global Markets for ... This report focuses on ... updated review, including its applications in various applications. The ... which includes three main industries: pharmaceutical and biotechnology, food ...
Breaking Medicine Technology: